Mauricio G Cohen
Affiliation: University of Miami
- First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary interventionMauricio G Cohen
Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL 33136, USA
Circulation 122:614-22. 2010..Controlled anticoagulation is possible with the REG1 system, an RNA aptamer pair comprising the direct factor IXa inhibitor RB006 and its active control agent RB007...
- The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA GuidelinesMauricio G Cohen
Miller School of Medicine, University of Miami, 1400 N W 12th Avenue, Room 1179, Miami, FL 33136, USA
Am Heart J 158:263-70. 2009..We sought to identify patients with a greater probability of severe CAD to target those who could receive the greatest benefit from revascularization...
- Starting a transradial vascular access program in the cardiac catheterization laboratoryMauricio G Cohen
Cardiovascular Division, Miller School of Medicine, University of Miami, University of Miami Hospital, Miami, FL 33136, USA
J Invasive Cardiol 21:11A-17A. 2009..To establish a transradial program and offer the benefits of this approach to most patients, a dedicated interventionalist must incorporate peers and hospital staff to create a multidisciplinary team...
- Therapeutic goals in patients with refractory chronic anginaMauricio G Cohen
Universidad de Miami, Florida, USA
Rev Esp Cardiol 63:571-82. 2010..This review provides an update on therapeutic techniques and goals, and reinforces the need for a multidisciplinary approach to the management of patients with refractory angina...
- Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease programMauricio G Cohen
University of Miami Miller School of Medicine, FL, USA
Circulation 121:2294-301. 2010..We sought to determine whether racial/ethnic differences in evidence-based acute myocardial infarction care persist among hospitals participating in a national quality improvement program...
- ST-T wave abnormality in lead aVR and reclassification of cardiovascular risk (from the National Health and Nutrition Examination Survey-III)Apurva O Badheka
Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA
Am J Cardiol 112:805-10. 2013..Adding T-wave abnormalities in lead aVR to the Framingham risk score improves model discrimination and calibration with better reclassification of intermediate-risk subjects...
- Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVRClaudia A Martinez
Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
Catheter Cardiovasc Interv 82:300-11. 2013..With the expansion in the use of transcatheter valve therapies for aortic stenosis, the incidence of hemodynamically significant paravalvular regurgitation (PVR) has become a clinical challenge...
- Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach-A contemporary experienceMauricio G Cohen
Elaine and Sydney Sussman Cardiac Catheterization Laboratory, Cardiovascular Division, Depeartment of Medicine, University of Miami Hospital, Miller School of Medicine, Miami, Florida
Catheter Cardiovasc Interv 82:987-93. 2013..To assess the feasibility and outcomes in patients undergoing transvenous transseptal (TS) transcatheter aortic valve replacement (TAVR)...
- The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United StatesJoel A Lardizabal
Multidisciplinary Structural Heart Disease Program at the University of Miami Miller School of Medicine, Miami, Florida, USA
J Am Coll Cardiol 61:2341-5. 2013....
- Cerebral protection against left ventricular thrombus during transcatheter aortic valve replacement in a patient with critical aortic stenosisPeeyush M Grover
Division of Cardiology, Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida 33136
Tex Heart Inst J 40:477-80. 2013..We present a case in which an 86-year-old man with known left ventricular thrombus underwent successful transcatheter aortic valve replacement under cerebral protection. ..
- The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: A sub-analysis of the BRAVO studyBrian O'Neill
Cardiovascular Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida
Catheter Cardiovasc Interv 83:148-53. 2014..To determine the impact of suture-mediated vascular closure devices (VCDs) on net adverse clinical events (NACEs) after balloon aortic valvuloplasty (BAV)...
- Electrocardiographic abnormalities and reclassification of cardiovascular risk: insights from NHANES-IIIApurva O Badheka
University of Miami Miller School of Medicine, Miami, FL 33136, USA
Am J Med 126:319-326.e2. 2013..We aimed to assess the additive value of electrocardiogram (ECG) findings to risk prediction models for cardiovascular disease...
- Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunctionClaudia A Martinez
Cardiovascular Division, and Elaine and Sydney Sussman Cardiac Catheterization Laboratory, University of Miami Hospital, Miller School of Medicine, Miami, Florida, USA
Catheter Cardiovasc Interv 80:1201-9. 2012..To evaluate feasibility and technical outcomes in patients with aortic stenosis (AS) who have undergone high-risk procedures with continuous flow left ventricular (LV) assist, with the Impella 2.5 system (Abiomed, Danvers, MA)...
- Impact of iodinated contrast injections on percent diameter coronary arterial stenosis and implications for trials of intracoronary pharmacotherapies in patients with ST-elevation myocardial infarctionC Michael Gibson
Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Am J Cardiol 100:13-7. 2007....